Cigna Group $CI Shares Purchased by SteelPeak Wealth LLC

SteelPeak Wealth LLC increased its holdings in Cigna Group (NYSE:CI) by 614.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,068 shares of the health services provider’s stock after purchasing an additional 5,219 shares during the quarter. SteelPeak Wealth LLC’s holdings in Cigna Group were worth $1,670,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Dodge & Cox grew its holdings in Cigna Group by 4.0% in the third quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock valued at $2,682,231,000 after purchasing an additional 354,615 shares during the period. Sanders Capital LLC raised its stake in shares of Cigna Group by 0.5% during the 3rd quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock worth $2,256,469,000 after buying an additional 35,150 shares during the period. Capital Research Global Investors lifted its position in shares of Cigna Group by 140.2% during the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after buying an additional 1,855,897 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its position in shares of Cigna Group by 7.4% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,695,620 shares of the health services provider’s stock valued at $777,012,000 after buying an additional 186,880 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its stake in Cigna Group by 54.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock valued at $615,781,000 after acquiring an additional 753,865 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

NYSE CI opened at $270.30 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The stock’s fifty day moving average is $276.19 and its two-hundred day moving average is $279.13. The firm has a market capitalization of $71.23 billion, a P/E ratio of 12.19, a price-to-earnings-growth ratio of 0.94 and a beta of 0.26. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the company earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, research analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend was Thursday, March 5th. Cigna Group’s payout ratio is presently 28.13%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on CI. Mizuho set a $325.00 price target on shares of Cigna Group in a report on Friday, January 9th. Leerink Partners lifted their target price on shares of Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research report on Friday, February 6th. Guggenheim reissued a “buy” rating and set a $318.00 target price on shares of Cigna Group in a research note on Monday, February 2nd. Robert W. Baird reduced their price target on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a research report on Thursday, December 11th. Finally, Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $333.11.

Insider Activity

In other news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.